Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002052113-25-001826
Filing Date
2025-04-28
Accepted
2025-04-28 21:11:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5989
2 PowerOfAttorney.txt EX-24 2753
3 Item_7.txt EX-99 721
  Complete submission text file 0002052113-25-001826.txt   11284
Mailing Address 8-2-337, ROAD NO.3 BANJARA HILLS HYDERABAD K7 500-034
Business Address 8-2-337, ROAD NO.3 BANJARA HILLS HYDERABAD K7 500-034 91 40 49002900
DR REDDYS LABORATORIES LTD (Subject) CIK: 0001135951 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-61429 | Film No.: 25882347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 50 HUDSON YARDS NEW YORK NY 10001
Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5800
BlackRock, Inc. (Filed by) CIK: 0002012383 (see all company filings)

EIN.: 991116001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)